Yanying Li
- Oncology top 10%
- Lung Cancer Research Studies 14
- Cancer Immunotherapy and Biomarkers 7
- Peptidase Inhibition and Analysis 3
-
- Lung Cancer Treatments and Mutations 23
- Lung Cancer Diagnosis and Treatment 9
- Brain Metastases and Treatment 3
-
- Adaptive optics and wavefront sensing 3
-
- PI3K/AKT/mTOR signaling in cancer 3
- Journals
- Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (1 paper)Nano Letters (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Yanying Li
53 papers receiving 662 citations
Peers
Comparison fields: 5 of 106
- Oncology 247
- Pulmonary and Respiratory Medicine 207
- Radiology, Nuclear Medicine and Imaging 117
- Immunology 98
- Otorhinolaryngology 14
Countries citing papers authored by Yanying Li
This map shows the geographic impact of Yanying Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanying Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanying Li more than expected).
Fields of papers citing papers by Yanying Li
This network shows the impact of papers produced by Yanying Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanying Li. The network helps show where Yanying Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yanying Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 9 | |
| 3 | 2023 | 12 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 19 | |
| 7 | 2022 | 8 | |
| 8 | 2021 | 51 | |
| 9 | 2021 | 4 | |
| 10 | 2020 | 1 | |
| 11 | 2020 | 101 | |
| 12 | 2020 | 3 | |
| 13 | 2018 | 2 | |
| 14 | 2018 | 6 | |
| 15 | 2018 | 28 | |
| 16 | 2017 | 1 | |
| 17 | 2016 | 18 | |
| 18 | 2015 | 1 | |
| 19 | 2014 | 15 | |
| 20 | 2011 | 5 |
About Yanying Li
Yanying Li is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 57 papers that have together received 669 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Research Studies (14 papers), Lung Cancer Diagnosis and Treatment (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Adaptive optics and wavefront sensing (3 papers), Brain Metastases and Treatment (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Oncology (247 citations), Pulmonary and Respiratory Medicine (207 citations) and Radiology, Nuclear Medicine and Imaging (117 citations). Yanying Li has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Meijuan Huang, You Lü, Youling Gong, Lin Zhou, Xiaojuan Zhou, Guanyu Chen, Wenjie Zhai, Yahong Wu, Xiuman Zhou and Li Ren. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nano Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.